F.D.A. Turmoil Keeps Spotlight on Its Commissioner NYT | Top Stories Christina Jewett 19 December 2025 at 18:01 The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership of Dr. Marty Makary. © Al Drago for The New York TimesDr. Marty Makary, the F.D.A. commissioner, has faced intense criticism as the agency undergoes top-level turnover in critical areas like drug approvals.
Login
